Clinical Data

GlobalMed to Unveil Enhanced Virtual Health Platform and New Delivery Systems at HIMSS20 | PR Newswire | 2/26/2020

… its virtual health platform eNcounter®, introduce a backpack telehealth exam station, and offer a lighter, more affordable exam camera at HIMSS20, March 9-13 in Orlando, FL. Enhancements to GlobalMed’s eNcounter platform include: FHIR-enabled, clinical data integration that facilitates the flow of portable virtual health data between health information systems. This allows important evidence to be queried from and stored in any FHIR-compatible system (i.e. EHR, practice management solutions …

$15.7 Billion eClinical Solutions Market Insights, 2020-2027: Focus on ECOA, EDC and CDMS | PR Newswire | 2/26/2020

… to fuel the demand for eClinical solutions.Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years. As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development process are poised to boost the market over the forecast period.Moreover, digital transformation in the field of clinical trials …

Follow Clinical Data:    

eClinical Solutions Market Size to Hit US$ 13.6 Bn by 2026 | PR Newswire | 2/18/2020

… research & development, and investment by multinational players are expected to propel the market growth during the forecast period. Based on the product the market has been segmented into ECOA, EDC & CDMS, Clinical Analytics Platforms, Clinical data integration platforms, Safety solutions, CTMS, RTSM, and eTMF. The electronic data capture (EDC) and clinical data management system (CDMS) accounted for the maximum share of the eClinical solutions market in 2018. However, the electronic …

eClinical Solutions Market Size Worth $15.7 Billion by 2027 | CAGR: 13.8%: Grand View Research, Inc. | PR Newswire | 2/10/2020

… www.grandviewresearch.com/industry-analysis/eclinical-solutions-market Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years. As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development process are poised to boost the market over the forecast period. Moreover, digital transformation in the field of clinical …

PatientPing Adds CommonWell Health Alliance’s Executive Director to Lead Strategic Partnership Initiatives | PR Newswire | 1/28/2020

… of connected providers. Jitin was the first Executive Director of CommonWell Health Alliance. He co-founded and led the alliance of 75+ health IT and healthcare organizations to build an innovative nationwide network for clinical data exchange. Under his leadership, the network grew from inception to 15,000+ live clinical facilities and saw 75M+ unique individuals enrolled. Prior to CommonWell, Jitin helped build athenahealth’s cloud-based interoperability platform and co-launched …

How interoperability will help unlock the value of clinical data | 1/21/2020

… sharing of clinical information, including medical records, laboratory results, clinical summaries, medication lists and much more. Today, health systems have established a foundational data exchange within their clinical environments, but among office-based physicians, clinical data interoperability has not gained a firm foothold. And unless every stakeholder participates, interoperability cannot realize its potential, and quality is compromised. The grand vision of healthcare interoperability is to remove the structural, technical and …

Clinical Data Exchange Market : The Next Booming Segment in the World:PNT Data; Health Level Seven International; New England Healthcare Exchange Network, Inc.; Optum, In | 1/16/2020

Clinical Data Exchange Market : The Next Booming Segment in the World:PNT Data; Health Level Seven International; New England Healthcare Exchange Network, Inc.; Optum, In Global Clinical Data Exchange Market – Industry Trends and Forecast to 2026 Pune, India – ( SBWIRE ) – 01/16/2020 – Global clinical data exchange market is expected to register a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the …

SCL Health to apply analytics to improve surgical outcomes, costs | Becker’s Hospital Review | 12/26/2019

SCL Health to apply analytics to improve surgical outcomes, costs Andrea Park - Print Email Broomfield, Colo.-based SCL Health has partnered with Empiric Health, a clinical data analytics company launched by Salt Lake City-based Intermountain Healthcare, to make data-driven improvements to surgical care quality and costs. Through the partnership, Empiric Health’s artificial intelligence-enabled analytics software will identify areas for improvement in surgical planning processes and care delivery …

Clinical Data Analytics Market Anticipated to Grow Rapidly During 2027 – IBM Corporation, Koninklijke Philips, McKesson Corporation, Optum, Oracle Corporation | 12/20/2019

Press Releases Clinical Data Analytics Market Anticipated to Grow Rapidly During 2027 – IBM Corporation, Koninklijke Philips, McKesson Corporation, Optum, Oracle Corporation The report covers key developments in the in clinical data analytics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and …

(USA-GA-Marietta) Manager, Clinical Data Governance | 12/8/2019

WellStar Health Systems Manager, Clinical Data Governance in Marietta , Georgia Overview At WellStar, we all share common goals. That’s what makes us so successful – and such an integral part of our communities. We want the same things, for our organization, for our patients, and for our colleagues. As the most integrated healthcare provider in Georgia, this means we pride ourselves on investing in the communities that we serve. We continue …

Stanford University Medical Center to Acquire Second Accuray CyberKnife® M6™ System | PR Newswire | 12/4/2019

… to achieve widespread market acceptance of its products, including new product offerings and improvements; the company’s ability to develop new products or improve existing products to meet customers’ needs; the company’s limited long-term clinical data supporting the safety and efficacy of its products, including product improvements, for certain users and such other risks identified under the heading “Risk Factors” in the company’s quarterly report on Form 10-Q, filed …

Biotechs Move Forward Developing Latest Targeted Therapies for Acute Myeloid Leukemia | PR Newswire | 12/4/2019

… trials to treat DME. Outlook Therapeutics intends to initiate NORSE 4, 5 and 6 in 2020. “We are very pleased to reach these agreements with the FDA so that we can continue to build clinical data for additional retinal indications beyond wet AMD for ONS-5010,” said Lawrence A. Kenyon , President, Chief Executive Officer and Chief Financial Officer. “Anti-VEGF therapy has been the standard of care for years within …

ViewRay Announces Pricing of Public Offering of Common Stock | PR Newswire | 12/4/2019

… offering price, less underwriting discounts and commissions. ViewRay intends to use the net proceeds from the offering for working capital and general corporate purposes, including capital expenditures, research and development expenses, investments, commercial expenses, clinical data generation costs and infrastructure expenses. The offering is expected to close on or about December 6, 2019 , subject to satisfaction of customary closing conditions. Elekta AB (Nasdaq: EKTA -B.ST), an affiliate of Medtronic (NYSE …

Crwe World | Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease | 12/4/2019

… pleased with this first notice of allowance that we’ve received from this international patent family, and we expect to receive many more in the months from jurisdictions around the world, including the United States.” Clinical data for Eltoprazine in PD-LID The Eltoprazine study in 22 subjects with long standing PD-LID was a randomized, four-way crossover design in which patients received a single dose of placebo and eltoprazine …

Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinsons Disease | 12/4/2019

… by United Parkinson’s Disease Rating Scale (UPDRS Part III) observation. Additionally, all dose levels of eltoprazine were well tolerated with no major adverse effects reported. A link to the publication of the PD LID clinical data is provided here: https://academic.oup.com/brain/article/138/4/963/280283/Eltoprazine-counteracts-L-DOPA-induced-dyski… Amarantus has entered into a binding term sheet for Elto Pharma to license eltoprazine to Emerald Organic Products. The transaction …

Healthcare IT Integration Market - Global Forecast to 2024 | PR Newswire | 12/4/2019

… Solutions Help Laboratories By Improving Workflows & Minimizing Error Occurrence 8.4 Clinics 8.4.1 Rising Need for Patient Information Exchange Across Different Healthcare Facilities to Support Market Growth 8.5 Diagnostic Imaging Centers 8.5.1 Growing Volume of Clinical Data & Rising Need to Streamline Imaging Workflows are Driving Market Growth 8.6 Other End Users 9 Healthcare IT Integration Solutions Market, By Region 10 Competitive Landscape 10.1 Overview 10.2 Market Ranking/Share Analysis 10.2.1 Healthcare …

Angiopoietin-2 predicts morbidity in adults with Fontan physiology | Nature | 12/4/2019

… years prior to study inclusion, and one patient with residual small fenestration at the time of cardiac catheterization. The average Fontan pressure during cardiac catheterization was 15.3 ± 5.0 mmHg. Table 1 Baseline Demographic and Clinical Data of Study Group. Full size table Forty percent of Fontan patients had evidence of PAVM at the time of plasma collection, while no ASD patients had PAVMs. One Fontan patient had a history of …

Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer’s Disease (CTAD) 2019 Conference Nasdaq:AVXL | Globe Newswire | 12/4/2019

… Significantly lower Cognitive Decline Compared to the ADNI Control Cohort at Interim 2-Year (104-Week) Timepoint Abundance of Lachnospiraceae and Enterobacteriaceae Families as Potential Biomarker of Response from a 2-Year Study Interim Clinical Data Analysis of ANAVEX ® 2-73 ( blarcamesine ) NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of …

Sleep Center Software Company Partners With Sleep AI Company to Accelerate Growth and Versatility | PRWeb | 12/4/2019

… all management components, including DME, workflow tasks, scheduling, EMR, patient and physician portals, patient communication, smart fax and credit card integration, and billing/claims and collections. EnsoData’s waveform AI leverages a wealth of archived clinical data to train its proprietary artificial intelligence engine, analyzing complex data streams with speed and accuracy. By improving the efficiency of clinician scoring, sleep centers can repurpose time to increase home sleep testing volume, reduce …

Researchers Leverage CBD’s Medical Properties to Fight a Plethora of Ailments | PR Newswire | 12/4/2019

… by United Parkinson’s Disease Rating Scale (UPDRS Part III) observation. Additionally, all dose levels of eltoprazine were well tolerated with no major adverse effects reported. A link to the publication of the PD LID clinical data is provided here: https://academic.oup.com/brain/article/138/4/963/280283/Eltoprazine-counteracts-L-DOPA-induced-dyskinesias Amarantus has entered into a binding term sheet for Elto Pharma to license eltoprazine to Emerald Organic Products. The transaction …

Clinical Data Integration

GlobalMed to Unveil Enhanced Virtual Health Platform and New Delivery Systems at HIMSS20 | 2/27/2020

clinical data integration that facilitates the flow of portable virtual health data between health information systems. This allows important evidence to be queried from and stored in any FHIR-compatible system (i.e. EHR, practice management solutions, etc.). Dynamic Integration Management Service (DIMS) — Facilitates automated sync with FHIR endpoints so that over time, eNcounter is always configured and compatible with an integrated platform. In doing so, DIMS minimizes the cost of …

Telehealth

GlobalMed to Unveil Enhanced Virtual Health Platform and New Delivery Systems at HIMSS20 | 2/27/2020

telehealth exam station featured in Booth 6089 GlobalMed , a leading provider of virtual health solutions, announced that it will showcase integration enhancements to its virtual health platform eNcounter, introduce a backpack telehealth exam station, and offer a lighter, more affordable exam camera at HIMSS20, March 9-13 in Orlando, FL. Omnichannel Payments App BharatPe Scoops $75 Million In Series C Funding Enhancements to GlobalMed’s eNcounter platform include: FHIR-enabled, clinical data

Clinical Research

eClinical Solutions Market Size to Hit US$ 13.6 Bn by 2026 | PR Newswire | 2/18/2020

… forecast period. North America consists of the U.S. and Canada . Both countries have high admeoption of innovative software solutions for clinical research. Furthermore, high government funding to support clinical trials, local presence of prominent players … has been segmented into ECOA, EDC & CDMS, Clinical Analytics Platforms, Clinical data integration platforms, Safety solutions, CTMS, RTSM, and eTMF. The electronic data capture (EDC) and clinical data management system (CDMS) accounted for the maximum …

Global eClinical Solutions Market, 2018-2027: Drivers, Restraints, Threats & Opportunities – ResearchAndMarkets.com | Financial Buzz | 1/21/2020

… reach $17.51 billion by 2027 growing at a CAGR of 14.8% during the forecast period. Technological advancement, government emphasis on clinical research and growing integration of software solutions in clinical trials are the major factors … 7 Global eClinical Solutions Market, By Product 7.1 Introduction 7.2 Clinical Data Integration Platforms 7.3 Clinical Data Management Systems (CDMS) 7.4 Clinical Analytics Platforms 7.5 Clinical Trial Management Systems 7.6 Electronic Data Capture (EDC) 7.7 …

Population Health

Population Health Management Market Is Expected to Exhibit a CAGR of 22.4% By 2023 | ABNewswire | 1/31/2020

Population Health Management Market Is Expected to Exhibit a CAGR of 22.4% By 2023 Posted on by admin Population Health Management Market Population Health Management Market Information: Component (Hardware and Others), Solution (Data Integration & Management … comprises real-time data exploration, financial data integration, data warehousing, clinical data integration, and others. The analytics segment has predictive analytics, point of care decision support, and others. The patient engagement segment includes multimodal communication …

How interoperability will help unlock the value of clinical data | 1/21/2020

… the kind of information liquidity and transparency that is standard in banking, retail and other transactional industries. Data—and particularly clinical data—is becoming the currency of healthcare, and this asset is often trapped within … being fueled by heightened patient expectations and industry innovations including population health, value-based care, mobile applications and non-traditional care modalities. Fully deployed, clinical interoperability will increase productivity and reduce operating costs; reduce errors …

Clinical Data Exchange

The Da Vinci Project, Part I: FHIR for Quality Measures and Gaps in Care | 1/31/2020

… to efforts to improve patient outcomes. As Rick Krohn, President of HealthSense, stated in a recent article , “Data—and particularly clinical data—is becoming the currency of healthcare, and this asset is often trapped within … Utilization Management and Prior Authorization Support Part II: FHIR for Clinical Data Exchange between Provider and Payer Part I: FHIR for Quality Measures and Gaps in Care Data Exchange for Quality Measures Per HL7 , data …

PatientPing Adds CommonWell Health Alliance’s Executive Director to Lead Strategic Partnership Initiatives | PR Newswire | 1/28/2020

clinical data exchange. Under his leadership, the network grew from inception to 15,000+ live clinical facilities and saw 75M+ unique individuals enrolled. Prior to CommonWell, Jitin helped build athenahealth’s cloud-based interoperability platform and co-launched the Argonaut project. “As an industry, we have an opportunity and an obligation to improve patient care through better collaboration and data exchange,” said Jay Desai , CEO of PatientPing. “At PatientPing, we are building …

CommonWell Health Alliance

PatientPing Adds CommonWell Health Alliance’s Executive Director to Lead Strategic Partnership Initiatives | PR Newswire | 1/28/2020

PatientPing Adds CommonWell Health Alliance’s Executive Director to Lead Strategic Partnership Initiatives Jitin Asnaani to Accelerate the Growth of PatientPing’s Care Collaboration Platform via Strategic Partnerships News provided by Jan 28, 2020, 09:21 ET Share … and healthcare organizations to build an innovative nationwide network for clinical data exchange. Under his leadership, the network grew from inception to 15,000+ live clinical facilities and saw 75M+ unique individuals enrolled. Prior to CommonWell …

PatientPing Adds CommonWell Health Alliance’s Executive Director to Lead Strategic Partnership Initiatives | BioSpace | 1/28/2020

… 2020 /PRNewswire/ – PatientPing, the nation’s leading care collaboration platform, announced today that it has named the former Executive Director of CommonWell Health Alliance, Jitin Asnaani, as Vice President of Strategic Partnerships. Jitin will leverage his … and healthcare organizations to build an innovative nationwide network for clinical data exchange. Under his leadership, the network grew from inception to 15,000+ live clinical facilities and saw 75M+ unique individuals enrolled. Prior to CommonWell …

Clinical Data Analytics

SCL Health to apply analytics to improve surgical outcomes, costs | Becker’s Hospital Review | 12/26/2019

SCL Health to apply analytics to improve surgical outcomes, costs Andrea Park - Print Email Broomfield, Colo.-based SCL Health has partnered with Empiric Health, a clinical data analytics company launched by Salt Lake City-based Intermountain Healthcare, to make data-driven improvements to surgical care quality and costs. Through the partnership, Empiric Health’s artificial intelligence-enabled analytics software will identify areas for improvement in surgical planning processes and care delivery …

Global Healthcare Analytics Markets, 2019-2024 by Type, Solution, Deployment Model, Application, End-user, and Geography – ResearchAndMarkets.com | Financial Buzz | 12/24/2019

Clinical Data Analytics 8.2. Financial Data Analytics 8.3. Risk Management Analytics 8.4. Others 9. Healthcare Analytics Market by End-Users 9.1. Healthcare Professionals 9.2. Pharmaceutical Companies 9.3. Research Organizations 10. Healthcare Analytics Market by Geography 10.1. North America 10.1.1. USA 10.1.2. Canada 10.1.3. Mexico 10.2. South America 10.2.1. Brazil 10.2.2. Argentina 10.2.3. Others 10.3. Europe 10.3.1. UK 10.3.2. Germany 10.3.3. Italy 10.3.4. Spain 10.3.5. Others 10.4. Middle East and Africa …

Clinical Pharmacology

Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients | 12/18/2019

… these HLAs are common in the Japanese population. 5. Discussion 5.1. Clinical Features of Hepatic irAE Here, we examined a clinical dataset of patients with ICI-induced liver injury, i.e., hepatic irAE. The hepatic irAE … Case definition and phenotype standardization in drug-induced liver injury,” Clinical Pharmacology & Therapeutics , vol. 89, no. 6, pp. 806–815, 2011. View at Publisher · View at Google Scholar · View at Scopus F. Gelsomino, G. Vitale …

2 Day Pharmacovigilance Europe Congress, 2020 (London, United Kingdom - May 19-20, 2020) | Benzinga | 12/4/2019

Clinical Pharmacology Clinical Safety Information And Clinical Data Management Medical Product Safety Assessment Clinical Research & Safety Data Analysis Information Technology Medical Information Health Outcomes Sales And Marketing Clinical Trials & CRO’s Contract Manufacturing Agenda DAY ONE 8.30AM - 9.30AM Registration & Refreshments 9.30AM - 9.45AM Chair Person Opening Remarks 09.45AM - 10.30AM Risk Management In Pharmacovigilance 10.30AM - 11.00AM Synergies Between Regulatory Affairs And Pharmacovigilance Budhesh Dhamija, Senior Manager, Regulatory Intelligence and Policy Europe 11.00AM - 11.15AM …

Mobile Patient Engagement

Compulink Announces New Capability to Connect to Multiple Specialty Registries | 12/14/2019

… all-in-one, specialty-specific EHR, and practice management solution, today announced a partnership with FIGmd, the leading developer of clinical data registries. This partnership will provide Compulink’s clients with the capability to connect to … management, ASC , optical POS (for eyecare providers), e-commerce, and mobile patient engagement. The company also provides an expert revenue cycle management service for its clients. Advantage meets QPP reporting requirements as a 2015 ONC …

Clinical Data Warehouse

Study Finds Over 70% of Adopters Judge Precision Medicine Informatics Initiatives as Nearing or Exceeding Expectations | BioSpace | 12/11/2019

clinical data warehouse solutions. Furthermore, the research indicates that the next wave of PMI technology expected to be adopted includes care team collaboration, tools to refer patients to certified genetic counselors, biomedical analytics solutions and quality reporting capabilities. “While precision medicine is becoming more mainstream, it is still a nascent discipline. Sharing the details of initiatives across the healthcare community will serve to accelerate adoption and determine future best practices …

Molecular Health And Red Hat: Stability And Innovation | 11/25/2019

Molecular Health And Red Hat: Stability And Innovation 2019-11-25 E-3 Magazine Molecular Health, a biomedicine company, uses analytics to provide comprehensive medical and therapeutic services. The company previously used a Suse Linux platform to support its SAP Hana environment for its clinical data warehouse but faced availability issues. By deploying Red Hat Enterprise Linux for SAP Hana – supported by backup software from Bacula Systems, a Red Hat partner – Molecular …

McKesson

Global Healthcare Analytics Markets, 2019-2024 by Type, Solution, Deployment Model, Application, End-user, and Geography – ResearchAndMarkets.com | Financial Buzz | 12/24/2019

… Others 7. Healthcare Analytics Market by Deployment Model 7.1. On Premise 7.2. Cloud 8. Healthcare Analytics Market by Application 8.1. Clinical Data Analytics 8.2. Financial Data Analytics 8.3. Risk Management Analytics 8.4. Others 9. Healthcare … Health Catalyst 12.6. Geneia 12.7. Verisk Analytics 12.8. MedeAnalytics 12.9. McKesson For more information about this report visit https://www.researchandmarkets.com/r/2e5gyr View source version on businesswire.com: https://www.businesswire.com/news/home/20191223005525/en …

Global Healthcare Analytics Markets, 2019-2024 by Type, Solution, Deployment Model, Application, End-user, and Geography - ResearchAndMarkets.com | Business Wire | 12/23/2019

… Others 7. Healthcare Analytics Market by Deployment Model 7.1. On Premise 7.2. Cloud 8. Healthcare Analytics Market by Application 8.1. Clinical Data Analytics 8.2. Financial Data Analytics 8.3. Risk Management Analytics 8.4. Others 9. Healthcare … Health Catalyst 12.6. Geneia 12.7. Verisk Analytics 12.8. MedeAnalytics 12.9. McKesson For more information about this report visit https://www.researchandmarkets.com/r/2e5gyr Contacts ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours …

Novartis

First Industry Datasets Submitted to ASH Research Collaborative Data Hub | PR Newswire | 12/4/2019

WASHINGTON , Dec. 4, The ASH Research Collaborative (ASH RC) has collaborated with two industry leaders, Novartis Pharmaceuticals Corporation (Novartis) and Amgen, to include de-identified patient data from three separate studies of nearly 500 patients … Hub, a platform designed to accelerate scientific discovery by gathering clinical data on rare blood diseases. Clinical trials are essential to identify new approaches to the prevention and treatment of hematologic diseases. People who take …

The return of the megamerger | 12/2/2019

… in the Chinese biopharma firm BeiGene. Gilead Sciences pays Galapagos $5.1 billion as part of a 10-year research pact. Novartis pays Takeda Pharmaceutical $3.4 billion to acquire the dry-eye treatment Xiidra. Pfizer merges … is less heady today, in part because the release of clinical data for hyped drug candidates is bringing values down to reality. Those same assets this year cost closer to $5 billion or $10 billion …

Pfizer

2019 Executive Director’s annual report | The Bulletin | 12/4/2019

… surgeons (MIPS-Qualified Registry) ACS Surgical Phases of Care Measures includes options for a range of surgical specialties (MIPS-Qualified Clinical Data Registry [QCDR]) The ACS Surgical Phases of Care QCDR includes a measure for … signaling a step forward for OGB’s advocacy agenda. Five ACS-Pfizer Surgical Volunteerism and Humanitarian Award recipients were honored at the B/G dinner and presented their work at Clinical Congress. OGB hosted the third …

Nektar Appoints John Northcott as Chief Commercial Officer - GuruFocus.com | 12/3/2019

… a variety of therapeutic areas from previous commercial leadership and management positions at other pharmaceutical companies including Lexicon, Merck and Pfizer. “I am excited to join Nektar and help build the company’s commercial function,” said … commencement or end of clinical studies and the availability of clinical data may be delayed or unsuccessful due to regulatory delays, slower than anticipated patient enrollment, manufacturing challenges, changing standards of care, evolving regulatory requirements …

Amgen

First Industry Datasets Submitted to ASH Research Collaborative Data Hub | PR Newswire | 12/4/2019

… WASHINGTON , Dec. 4, The ASH Research Collaborative (ASH RC) has collaborated with two industry leaders, Novartis Pharmaceuticals Corporation (Novartis) and Amgen, to include de-identified patient data from three separate studies of nearly 500 patients … Hub, a platform designed to accelerate scientific discovery by gathering clinical data on rare blood diseases. Clinical trials are essential to identify new approaches to the prevention and treatment of hematologic diseases. People who take …

Amgen Announces Data Being Presented At ASH 2019 | BioSpace | 12/3/2019

THOUSAND OAKS, Calif. , Dec. 2, 2019 /PRNewswire/ – Amgen (NASDAQ:AMGN) today announced new clinical data from its oncology in-line products and pipeline that will be presented at the 61 st American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando , Dec. 7-10, 2019 . The Phase 3 CANDOR study, which was accepted as a late-breaking abstract, evaluated KYPROLIS ® (carfilzomib) in combination with dexamethasone and DARZALEX ® (daratumumab) (KdD) compared to …

Celgene

Here’s Why Editas Medicine Jumped 45.3% in November | The Motley Fool | 12/4/2019

… Market Intelligence . The gene editing pioneer rose for reasons both internal and external. The business announced an amended collaboration with Celgene ( NASDAQ:CELG ) for developing engineered immune cells and will receive an upfront payment of … in early 2020. The company also expects to report pre-clinical data for EDIT-301, being developed for the same blood disorders as CTX001, before the end of 2019. All things being equal, if it …

Kyn Therapeutics Rebrands as Ikena Oncology, Reflecting Next Phase of Growth | BioSpace | 12/3/2019

… Ikena has five development and discovery programs with multiple clinical and regulatory milestones expected in 2020, including report of preliminary clinical data on its lead program IK-007, an EP4 antagonist. Mark Manfredi, Ph.D., President … program is the subject of a global strategic collaboration with Celgene, now Bristol-Myers Squibb. IK-412: A highly potent and stable kynurenine-degrading enzyme (or “Kynase”) that may be able to overcome resistance to …

Medtronic

ViewRay Announces Pricing of Public Offering of Common Stock | PR Newswire | 12/4/2019

clinical data generation costs and infrastructure expenses. The offering is expected to close on or about December 6, 2019 , subject to satisfaction of customary closing conditions. Elekta AB (Nasdaq: EKTA -B.ST), an affiliate of Medtronic (NYSE: MDT ) and an affiliate of ViewRay’s largest shareholder, Fosun International Limited, will each be consummating their previously-announced investments in ViewRay by participating in this offering. Piper Jaffray & Co. is acting as the lead …

GSK

2 Day Pharmacovigilance Europe Congress, 2020 (London, United Kingdom - May 19-20, 2020) | Benzinga | 12/4/2019

… experience in the following areas: Pharmacovigilance Risk Management Drug Safety Pharmacoepidemiology Drug Research & Development Clinical Pharmacology Clinical Safety Information And Clinical Data Management Medical Product Safety Assessment Clinical Research & Safety Data Analysis Information Technology Medical … 12.30PM PV Audits And Inspections Manjit Virdee, PV QA Manager, GSK 12.30PM - 13.30PM Networking Luncheon 13.30PM - 14.00PM PV Outsourcing Jackie Roberts, Executive Director Regulatory, Pharmacovigilance and Medical UK/IE/Malta and MENA 14.00PM - 14.30PM Role …

2 Day Pharmacovigilance Europe Congress, 2020 (London, United Kingdom – May 19-20, 2020) | Financial Buzz | 12/4/2019

… experience in the following areas: Pharmacovigilance Risk Management Drug Safety Pharmacoepidemiology Drug Research & Development Clinical Pharmacology Clinical Safety Information And Clinical Data Management Medical Product Safety Assessment Clinical Research & Safety Data Analysis Information Technology Medical … 12.30PM PV Audits And Inspections Manjit Virdee, PV QA Manager, GSK 12.30PM – 13.30PM Networking Luncheon 13.30PM – 14.00PM PV Outsourcing Jackie Roberts, Executive Director Regulatory, Pharmacovigilance and Medical UK/IE/Malta and MENA 14.00PM – 14.30PM Role …

UnitedHealth Group

Social Worker Office Navigator - Baton Rouge, LA - UnitedHealth Group - Baton Rouge, LA | 12/4/2019

… secure. Follows corporate instruction based on Federal and State guidance related to health information documentation and security. Additional Competencies: access clinical data and draw conclusions think critically influence and effect change utilizing negotiation, conflict management … your life’s best work. SM Diversity creates a healthier atmosphere: UnitedHealth Group is an Equal Employment Opportunity/Affirmative Action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion …

(USA-TX-Fort Worth) MRI Tech | 11/24/2019

Job Information UnitedHealth Group MRI Tech in Fort Worth , Texas USMD part of OptumCare is a multi-specialty group of hospital, clinics and physicians. USMD serves the Dallas-Fort Worth metropolitan area with more than … and bringing together pertinent patient history, physical examination and supporting clinical data Comforts patients by explaining procedures and assisting patient in proper positioning. If bilingual, acts as a translator to assist patients and others that …

AbbVie

Crwe World | Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease | 12/4/2019

… family, and we expect to receive many more in the months from jurisdictions around the world, including the United States.” Clinical data for Eltoprazine in PD-LID The Eltoprazine study in 22 subjects with long … of PD-LID. Eltoprazine was originally developed by Solvay (now Abbvie) for aggression-related indications. The eltoprazine program was out-licensed to PsychoGenics, Inc. (PGI). PGI licensed eltoprazine to Amarantus in 2014 after a successful …

GE Healthcare

Healthcare IT Integration Market - Global Forecast to 2024 | PR Newswire | 12/4/2019

… this market include Allscripts Healthcare Solutions, Inc. Avi-Spl, Inc. Capsule Technologies, Inc. Cerner Corporation Corepoint Health Epic Systems Corporation GE Healthcare IBM Infor Interfaceware, Inc. Intersystems Corporation Koninklijke Philips Medical Information Technology, Inc. Nextgen … Market Growth 8.5 Diagnostic Imaging Centers 8.5.1 Growing Volume of Clinical Data & Rising Need to Streamline Imaging Workflows are Driving Market Growth 8.6 Other End Users 9 Healthcare IT Integration Solutions Market, By Region 10 …

GE Launches Program to Ease Artificial Intelligence Adoption | HealthIT Analytics | 11/27/2019

… help providers gain easier access to market-ready artificial intelligence algorithms and applications. Source: Getty Images By November 27, 2019 - GE Healthcare has launched the Edison Developer Program to accelerate artificial intelligence adoption and impact … Massachusetts General Hospital and Brigham and Women’s Hospital Center for Clinical Data Science. The collaboration currently includes 15 active projects within areas such as women’s health, cardiology, oncology, hospital operations, and emergency medicine. GE Healthcare

SVB Leerink

Ex-Sequoia VC Michael Dixon on digital health investment strategy - Business Insider | 12/4/2019

… Sequoia alum Todd Cozzens and Dr. Jared Kesselheim at Transformation Capital , the recently spun-out digital-health venture arm of SVB Leerink. The fund, which initially got its start within the bank in 2016, manages … said. Then, there are pharmaceutical companies looking to use digitized clinical data to aid in developing new treatments. “Now that we have clinical data, pharmaceutical companies are reimagining their business,” Dixon said. Already, Transformation Capital …

The return of the megamerger | 12/2/2019

… of deal: Cholesterol-lowering drug in late-stage studies Source: Companies According to an analysis done by the investment firm SVB Leerink, global pharmaceutical merger and acquisition activity is on track to hit a 10 … is less heady today, in part because the release of clinical data for hyped drug candidates is bringing values down to reality. Those same assets this year cost closer to $5 billion or $10 billion …

Morgan Stanley

Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics | Business Wire | 12/3/2019

… the impact of a consummation of the transaction on its financial results for the fiscal year ending March 31, 2020. Morgan Stanley & Co. LLC, acting through its affiliate Mitsubishi UFJ Morgan Stanley Securities Co., Ltd … Audentes’ product candidates, the timing of Audentes’ presentation of non-clinical data and the timing and nature of Audentes’ preclinical studies, clinical trials and manufacturing activities. In some cases, forward-looking statements may be identified …

Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics – Company Announcement - FT.com | Financial Times | 12/3/2019

… the impact of a consummation of the transaction on its financial results for the fiscal year ending March 31, 2020 . Morgan Stanley & Co. LLC , acting through its affiliate Mitsubishi UFJ Morgan Stanley Securities Co., Ltd … Audentes’ product candidates, the timing of Audentes’ presentation of non-clinical data and the timing and nature of Audentes’ preclinical studies, clinical trials and manufacturing activities. In some cases, forward-looking statements may be identified …

Alexandria Venture Investments

Cancer Therapeutics Market Size to Reach US$ 176 Bn by 2026 | PR Newswire | 11/27/2019

… 2026. Some of the key observations regarding Cancer Therapeutics industry include: Kymera Therapeutics Inc., a biotechnology company announced to present preclinical data demonstrating the potency and antitumor activity of a selective stat3 degrader at the … Inc. launched with US$50 Mn in financing from 3SBio, Alexandria Venture Investments, 20/20 HealthCare Partners, Highlight Capital, InHarv Partners Ltd., The Mark Foundation for Cancer Research and Yonghua Capital. The launch is intended to …

Alexandria Venture

Cancer Therapeutics Market Size to Reach US$ 176 Bn by 2026 | PR Newswire | 11/27/2019

… 2026. Some of the key observations regarding Cancer Therapeutics industry include: Kymera Therapeutics Inc., a biotechnology company announced to present preclinical data demonstrating the potency and antitumor activity of a selective stat3 degrader at the … Inc. launched with US$50 Mn in financing from 3SBio, Alexandria Venture Investments, 20/20 HealthCare Partners, Highlight Capital, InHarv Partners Ltd., The Mark Foundation for Cancer Research and Yonghua Capital. The launch is intended to …

JP Morgan

MC2 Therapeutics Announces FDA Acceptance of its New Drug Application for Wynzora™ Cream for Treatment of Plaque Psoriasis | BioSpace | 11/22/2019

… User Fee Act (PDUFA) action date. MC2 Therapeutics’ NDA for Wynzora™ Cream is comprised of extensive quality, non-clinical and clinical data. Specifically, data from the pivotal phase 3 trial demonstrated that Wynzora™ Cream treatment … 20th-21st 2019 Dermatology Summit, San Francisco, January 12th 2020 JP Morgan Healthcare Conference, San Francisco, 13th -16th January 2020 Winter Clinical, Hawaii, January 16th–19th 2020 …

Tricida Inc (TCDA) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/15/2019

… of metabolic acidosis slows the progression of kidney disease. Furthermore, we’ll be ready to walk through all of our veverimer clinical data, including results beyond the surrogate endpoint such as improvements in how the patient … next question comes from the line of Jessica Fye from JP Morgan. Your question please. Jessica M. Fye – JPMorgan – Analyst Hey guys, good afternoon. Thanks for taking my question. With the VALOR trial expected to …

SV Health Investors

EBT Secures USD $10M Series A | Benzinga | 11/20/2019

SV Health Investors and Genesys Capital. EBT intends to use the funding to further develop its revolutionary noninvasive neuromodulation technology, as well as to pursue additional clinical data validating its safety and effectiveness. Funding will also be used to expand the management team and for general administrative purposes. “Having SV and Genesys on board is an extremely important step as EBT enters a new phase of growth,” said Keith R …

Goldman Sachs

“More Rarified Air (Karuna)!” Vista Partners Daily Market Recap 11/18/19 | 11/19/2019

… and terms of the offering. All the shares to be sold in the proposed offering will be sold by Karuna. Goldman Sachs & Co. LLC and Citigroup are acting as joint book-running managers for the … payment, the new study will allow us to update our clinical data which we believe will allow us to show improved clinical pregnancy and birth rates and further enhance the value proposition we can provide …

INVO Bioscience, Developers Of The World’s Only In Vivo FDA Cleared Intravaginal Culture System, Will Host A Live Investor Webcast at 11:00 AM ET (8:00 am PT) on Thursday, November 21, 2019 | 11/19/2019

… benefits management company specializing in fertility and family building benefits solutions in the United States. PGNY priced its J.P. Morgan, Goldman Sachs & Co. LLC and BofA Securities led initial public offering at $13.00 per share … payment, the new study will allow us to update our clinical data which we believe will allow us to show improved clinical pregnancy and birth rates and further enhance the value proposition we can provide …

JMP Securities

“More Rarified Air (Karuna)!” Vista Partners Daily Market Recap 11/18/19 | 11/19/2019

… as joint book-running managers for the offering. Stifel, Nicolaus & Company, Incorporated is also acting as a book-running manager. JMP Securities LLC is acting as a lead manager. Progyny, Inc. (Nasdaq: PGNY) closed trading … payment, the new study will allow us to update our clinical data which we believe will allow us to show improved clinical pregnancy and birth rates and further enhance the value proposition we can provide …

Altimmune Announces Third Quarter 2019 Financial Results and Provides a Business Update | Globe Newswire | 11/13/2019

clinical data presented at multiple conferences Since acquiring ALT-801, a potent GLP-1/glucagon receptor dual agonist for the treatment of non-alcoholic steatohepatitis (NASH), the Company has presented the IND-enabling preclinical data and Phase 1 clinical trial plans at the H.C. Wainwright NASH Investor Day, the B. Riley NASH KOL Symposium, and the JMP Securities NASH Forum. ALT-801 is a peptide-based therapeutic candidate with balanced …

Deerfield Management

Bankrupt biopharmas are rare. 2019 has some worried that’s changing. | 11/19/2019

… platform companies like Moderna Therapeutics and Rubius Therapeutics went public with multi-billion dollar valuations despite lacking profits and significant clinical data. 2019 bankruptcies But investor attitudes appear to have shifted. Rubius’ stock, for instance … A can be another way out for shareholders. Firms like Deerfield Management, Hercules Capital and Highbridge Capital Management often aid distressed biotechs in such endeavours.Deerfield, for instance, reached deals to finance R&D costs for …

Frequency Therapeutics Provides Business Updates and Reports Third Quarter 2019 Financial Results | Business & Finance | heraldchronicle.com | Business Wire | 11/18/2019

… addition, FX-322 was observed to be well-tolerated with no serious adverse effects. The Company also presented preclinical and clinical data from the Phase 1/2 study at the 2 nd Annual International Symposium on … financing led by Perceptive Advisors and a syndicate that included Deerfield Management, RTW Investments, and Mizuho Securities Principal Investment. License and Collaboration Agreement with Astellas (July 2019) : Frequency entered into a license and collaboration agreement …

Needham & Company

Axonics Modulation Technlogs INC (AXNX) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/17/2019

… our clinical results from the pivotal clinical study facts that we have been able to share with physicians until today. Clinical data is of the-of critical importance to the customers that – our customer base … instructions] And our next question comes from Mike Matson from Needham & Company. Your line is now open. Mike Matson – Needham and Company – Analyst Hi. Thanks for taking my questions. Just a couple of manufacturing-related …

Omeros (OMER) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/13/2019

… like OMIDRIA that have demonstrated the ability to replace or reduce use of opioids in a clinical trial or through clinical data published in a peer-reviewed journal. Separate payment would run for five years … you. And our next question comes from Serge Belanger with Needham & Company. Please proceed with your question. Serge Belanger – Needham and Company – Analyst Hi, good afternoon. Just a couple of questions for me. First, Greg …

WellStar Health System

(USA-GA-Marietta) Manager, Clinical Data Governance | 12/8/2019

WellStar Health Systems Manager, Clinical Data Governance in Marietta , Georgia Overview At WellStar, we all share common goals. That’s what makes us so successful – and such an integral part of our communities. We want the same things, for our organization, for our patients, and for our colleagues. As the most integrated healthcare provider in Georgia, this means we pride ourselves on investing in the communities that we serve. We continue …

Clinical Liaison - Marietta, GA, , USA #jobs #Marietta pls RT | 11/12/2019

Job Detail for Clinical Liaison Job Location: WellStar Health System, Marietta, GA, Clinical Liaison Job Location: WellStar Health System, Marietta, GA, , USA Jobs In Clinical Liai Marietta Jobs In Clinical Liai Ga Jobs In Clinical … verbal communication skills. Knowledgeable of screening criteria in review of clinical data with respect to patients/clients needs for healthcare. Ability to effect change performs critical analysis, promote client/family autonomy and plan and organize …

Massachusetts General Hospital

Visage demos semantic annotations at RSNA 2019 | 12/4/2019

Massachusetts General Hospital and Brigham and Women’s Hospital Center for Clinical Data Science – are piloting Visage 7. Copyright © 2019 AuntMinnie.com To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now. Member Sign In …

Christine Swisher | 12/3/2019

… Nathan White, PhD, CEO of HealthLytix. “Her unique expertise in leveraging AI and machine learning to integrate genetics, imaging, and clinical data will be invaluable to helping us expand and advance our portfolio of genetics … postdoctoral training in precision medicine at Harvard Medical School and Massachusetts General Hospital. About HealthLytix At HealthLytix, we’re using cutting-edge advances in genetics and medical imaging to revolutionize disease screening and early detection so …

Mayo Clinic

Risk Behaviors in Teens with Chronic Kidney Disease: A Study from the Midwest Pediatric Nephrology Consortium | 12/4/2019

… of Atlanta, Atlanta, GA, USA 9 Division of Nephrology, Seattle Children’s Hospital, Seattle, WA, USA 10 Division of Pediatric Nephrology, Mayo Clinic, Rochester, MN, USA 11 Division of Nephrology Kentucky Children’s Hospital, Lexington, KY, USA … to confirm causality. (2) Additionally, there is a lack of clinical data such as laboratory results and disease progression. Future studies are warranted to assess how risk behaviors may impact health outcomes. ASK KIDD does …

Amgen Announces Data Being Presented At ASH 2019 | BioSpace | 12/3/2019

THOUSAND OAKS, Calif. , Dec. 2, 2019 /PRNewswire/ – Amgen (NASDAQ:AMGN) today announced new clinical data from its oncology in-line products and pipeline that will be presented at the 61 st American Society of Hematology … cancer/acute-lymphoblastic-leukaemia-all/about . Accessed November 15, 2019 . Mayo Clinic. Acute lymphocytic leukemia. http://www.mayoclinic.org/diseases-conditions/acute-lymphocytic-leukemia/basics/definition/con-20042915 . Accessed November 15, 2019 . Paeitta E. Assessing minimal residual …

Partners HealthCare

Visage demos semantic annotations at RSNA 2019 | 12/4/2019

Partners HealthCare – founded by Massachusetts General Hospital and Brigham and Women’s Hospital Center for Clinical Data Science – are piloting Visage 7. Copyright © 2019 AuntMinnie.com To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now. Member Sign In …

NVIDIA Clara Federated Learning to Deliver AI to Hospitals | 12/2/2019

Partners HealthCare in New England also announced a new initiative using NVIDIA Clara FL. Massachusetts General Hospital and Brigham and Women’s Hospital’s Center for Clinical Data Science will spearhead the work, leveraging data assets and clinical expertise of the Partners HealthCare system. In the U.K., NVIDIA is partnering with King’s College London and Owkin to create a federated learning platform for the National Health Service. The Owkin Connect platform running …

Stanford University Medical Center

Stanford University Medical Center to Acquire Second Accuray CyberKnife® M6™ System | PR Newswire | 12/4/2019

SUNNYVALE, Calif. Accuray Incorporated (NASDAQ: ARAY ) announced today that Stanford University Medical Center has selected a second CyberKnife ® M6™ System to expand access to precise radiosurgery treatments to more of their patients. With its installation … products to meet customers’ needs; the company’s limited long-term clinical data supporting the safety and efficacy of its products, including product improvements, for certain users and such other risks identified under the heading “Risk …

Hackensack University Medical Center

COTA Presents Posters at ASH Annual Meeting, Reviewing Complexities of Generating RWD and How it Complements Traditional Clinical Trial Data | PR Newswire | 12/4/2019

clinical data in a timely, cost-free, and coded manner. A comprehensive, research-focused data abstraction process for coded data exchange is being established to support future RWD projects. Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma Researchers from COTA and Hackensack University Medical Center studied patients with newly diagnosed multiple myeloma who also had a history of prior malignancy …

Stanford University Medical Center, Stanford CA

Stanford University Medical Center to Acquire Second Accuray CyberKnife® M6™ System | PR Newswire | 12/4/2019

SUNNYVALE, Calif. Accuray Incorporated (NASDAQ: ARAY ) announced today that Stanford University Medical Center has selected a second CyberKnife ® M6™ System to expand access to precise radiosurgery treatments to more of their patients. With its installation … products to meet customers’ needs; the company’s limited long-term clinical data supporting the safety and efficacy of its products, including product improvements, for certain users and such other risks identified under the heading “Risk …

Vanderbilt University Medical Center

Genetic risk for major depressive disorder and loneliness in sex-specific associations with coronary artery disease | Nature | 12/3/2019

… risk factors for MDD and loneliness by conducting a phenome-wide association study in 18,385 European-ancestry individuals in the Vanderbilt University Medical Center biobank, BioVU. Polygenic scores for MDD and loneliness were developed for … an analysis based solely on GWAS summary statistics. Dense, longitudinal clinical data from large genotyped samples provide new opportunities to disentangle shared genetic risk factors from phenotypic hitchhiking. We hypothesized that pleiotropic genetic risk factors …

Research Nurse Specialist I, Pediatric Genetics - USA-TN-Nashville | 11/29/2019

… lock, study closeout and archiving of study files ensures completeness and continuity of all study data performs ongoing checks of clinical data that has been entered on the case report forms (paper or electronic) to … Registered Nurse Required Position Shift: Day Shift/Exempt Position Discover Vanderbilt University Medical Center: Located in Nashville, Tennessee, and operating at a global crossroads of teaching, discovery and patient care, VUMC is a community of …

Kaiser Permanente

Dynavax Announces HEPLISAV-B Post-Marketing Requirement Interim Report Completed | Globe Newswire | 12/3/2019

clinical data regarding the safety of HEPLISAV-B and support our confidence that HEPLISAV-B can be the emerging standard of care for preventing hepatitis B infection in adults,” commented Robert Janssen , MD, Chief Medical Officer. “We are pleased to collaborate with Kaiser Permanente Southern California for their rigorous conduct of this study, and look forward to a scientific presentation of the final data at an appropriate forum in the …

Dynavax Announces HEPLISAV-B Post-Marketing Requirement Interim Report Completed - GuruFocus.com | 12/3/2019

clinical data regarding the safety of HEPLISAV-B and support our confidence that HEPLISAV-B can be the emerging standard of care for preventing hepatitis B infection in adults,” commented Robert Janssen , MD, Chief Medical Officer. “We are pleased to collaborate with Kaiser Permanente Southern California for their rigorous conduct of this study, and look forward to a scientific presentation of the final data at an appropriate forum in the …

MD Anderson Cancer Center

The return of the megamerger | 12/2/2019

… chance of succeeding or failing, Hunzinger says. But the market is less heady today, in part because the release of clinical data for hyped drug candidates is bringing values down to reality. Those same assets … leadership and crisis experience: he steered the University of Texas MD Anderson Cancer Center out of financial and legal trouble, and while he was at the University of Pennsylvania, he took responsibility for shoddy treatment …

Sierra Oncology Announces Investor Event to Discuss Momelotinib Data Being Reported at ASH | PR Newswire | 12/2/2019

clinical data for momelotinib that will be presented at the 61st American Society of Hematology (ASH) Annual Meeting in Orlando, Florida . The event will be led by Dr. Nick Glover , President and CEO of Sierra Oncology, and will include a presentation by renowned myelofibrosis expert, Dr. Ruben Mesa , Director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center. Dr. Mesa and members of Sierra …

Humana

Consumer satisfaction lower for hospitals, higher for payers | Healthcare Finance | 11/28/2019

… hotels, which earned scores of 80, 79 and 75 respectively. Health insurers fared better. In fact, they earned their highest score in a decade, climbing to 74 from 73 a year ago, with Humana leading the charge among insurers with a score of 79. Trailing Humana was Kaiser Permanente (77) and Aetna (76). Aetna earned its highest score in the report’s history. UnitedHealthcare earned a score of 75. Falling below …

Humana’s Medicare Advantage value-based programs reduce healthcare costs by $3.5 billion, report shows | Healthcare Finance | 11/22/2019

Humana’s revenue is projected to increase on 17% rise in MA membership and premium increases, but return of HIF reduced workforce by 2%. Susan Morse , Senior Editor Medicare Advantage plans save the health system and … use electronic health records (EHRs) to collect and report on clinical data, practices often need help deciding what data to collect, which measures to report … Gaining Actionable Insight into Financial Systems and Areas Impacting the …

Cigna

“More Rarified Air (Karuna)!” Vista Partners Daily Market Recap 11/18/19 | 11/19/2019

… per share. Recently reports surfaced that publicly traded private equity firm KKR (KKR $29.46 +-1.27%) is preparing a buyout plan. Cigna (CI) closed +1.21% closing at $198.38/share. Worldwide, the fertility treatment market is severely … payment, the new study will allow us to update our clinical data which we believe will allow us to show improved clinical pregnancy and birth rates and further enhance the value proposition we can provide …

“Apparently Kudlow + Retail = 28k” Vista Partners Daily Market Recap 11/15/19 | 11/16/2019

… share. This week reports surfaced that publicly traded private equity firm KKR (KKR $29.84 +1.36%) is preparing a buyout plan. Cigna (CI) closed +3.33% closing at $196.01/share. Worldwide, the fertility treatment market is severely … payment, the new study will allow us to update our clinical data which we believe will allow us to show improved clinical pregnancy and birth rates and further enhance the value proposition we can provide …

Aetna

Health Insurers Are Vacuuming Up Details About You — And It Could Raise Your Rates — ProPublica | 11/18/2019

… the hospital within 30 days of their discharge. The company says it has validated its scores against insurance claims and clinical data. But it won’t share its methods and hasn’t published the work in peer … because she wanted to help people, but one day at Aetna, her boss told her to work with a new data set. To her surprise, the company had obtained personal information from a data broker …

Introducing Well: A Platform to Engage and Improve Employee Health | 11/15/2019

… clinical data, medical experience and dynamic incentives to improve employee health and lower costs.” Loveman led Caesars Entertainment and its more than 70,000 employees for 13 years. Subsequent to his tenure at Caesars, Loveman was President of Consumer Health at Aetna. The Well platform targets engagement with all employees and will initially be offered to employers to include as part of their employee benefit offerings. The company, based in Chapel …

Health New England

SI-BONE, Inc.’s (SIBN) CEO Jeff Dunn on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/12/2019

clinical data is a key component of growing positive support from clinical evaluation organizations and garnering payer wins, many of which are exclusive to iFuse based on this clinic evidence. Effective July 1, 2019, Vermont, Blue Cross, Blue Shield, which ensures approximately 1.5 million members in South Dakota and Iowa establish positive coverage for minimally invasive SI joint fusion. Additionally, effective September 1, 2019, Health New England, which ensures approximately …

SI-BONE, Inc. Reports Third Quarter 2019 Financial Results and Updates Full-Year 2019 Revenue Guidance | Globe Newswire | 11/11/2019

… Obtained positive coverage from Wellmark Blue Cross Blue Shield for 1.5 million members in South Dakota and Iowa and transitioned Health New England to exclusive iFuse coverage for minimally invasive SI joint fusion Announced the … the U.S. with the publication of our five-year prospective clinical data. We are also pleased with the decision by Medicare to increase the surgeon payment from $720 to $915 effective January 1, 2020, recognizing …

Wellmark Blue Cross Blue Shield

SI-BONE, Inc. Reports Third Quarter 2019 Financial Results and Updates Full-Year 2019 Revenue Guidance | Globe Newswire | 11/11/2019

… patients treated with iFuse Implant System, showing continued durability of clinical response and positive radiographic outcomes Obtained positive coverage from Wellmark Blue Cross Blue Shield for 1.5 million members in South Dakota and Iowa and … the U.S. with the publication of our five-year prospective clinical data. We are also pleased with the decision by Medicare to increase the surgeon payment from $720 to $915 effective January 1, 2020, recognizing …

SI-BONE, Inc. Reports Third Quarter 2019 Financial Results and Updates Full-Year 2019 Revenue Guidance Nasdaq:SIBN | Globe Newswire | 11/11/2019

… patients treated with iFuse Implant System, showing continued durability of clinical response and positive radiographic outcomes Obtained positive coverage from Wellmark Blue Cross Blue Shield for 1.5 million members in South Dakota and Iowa and … the U.S. with the publication of our five-year prospective clinical data. We are also pleased with the decision by Medicare to increase the surgeon payment from $720 to $915 effective January 1, 2020, recognizing …

Health Net

Digital Health Network members share their NHS IT nightmares | 10/31/2019

Shared Records Digital Health Network members share their NHS IT nightmares Digital Health News has been given a spooky makeover today to celebrate all things Halloween and we have asked members of the Digital Health … James “rotten” Reed, chair of the CCIO Network: “Imagining our clinical data being sealed up in a crate and lost forever in a warehouse like the end of ‘Raiders of the Lost Ark’. “Being tormented …

Insmed Reports Third Quarter 2019 Financial Results and Provides Business Update | PR Newswire | 10/30/2019

BRIDGEWATER, N.J. Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the third quarter ended September 30, 2019 and provided a business update. “We remain very pleased with the continued strong performance of the US launch of ARIKAYCE ® (amikacin liposome inhalation suspension). Insmed remains guided by our desire to have a positive …

Select Health

Global Urinalysis Industry | PR Newswire | 10/29/2019

NEW YORK Urinalysis market worldwide is projected to grow by US$927.5 Million , driven by a compounded growth of 7.3%. Consumables, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.8 Billion …

PTC Therapeutics Reports Third Quarter 2019 Financial Results and Provides a Corporate Update | PR Newswire | 10/29/2019

SOUTH PLAINFIELD, N.J. PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced a corporate update and reported financial results for the third quarter ending September 30, 2019 . “We are following through on our commitment to build an innovative, diversified rare disorders company,” said Stuart Peltz , Ph.D., CEO of PTC Therapeutics. “This quarter, we completed a successful financing to continue to drive our internal programs while continuing to evaluate select external opportunities. This …

UnitedHealthcare

Manager Clinical Data Operations El Paso TX 5000 Sign On Bonus For External Candidates - USA-TX-El Paso | 10/28/2019

… continuum of care. Join us and help people live healthier lives while doing your life’s best work.(sm)The Manager, Clinical Data Operationsmanages plans and organizes the DataRAP department staff and operations to ensure that … candidates. Candidates who are currently working for a UnitedHealth Group, UnitedHealthcare or a related entity in a full time, part time, or per diem basis (Internal Candidates) are not eligible to receive a sign on …

Diameter Health Names Terry Boch Chief Commercial Officer | 10/4/2019

Former IBM Watson Health and UnitedHealthcare Executive Brings Decades of Experience in Accelerating Healthcare Transformation to Leading Provider of Clinical Data Refinement FARMINGTON, Conn. Diameter Health , the company that cures clinical data disorder, today announced the appointment of Terry Boch as chief commercial officer, responsible for the company’s revenue-generating functions. Boch is a proven leader with over 30 years’ experience in healthcare IT. Her most recent position was vice …

Harvard Pilgrim Health Care

TriNetX Named Technology Partner for FDA Sentinel System | PR Newswire | 10/7/2019

… program that uses electronic health care data to monitor the safety of FDA-regulated drugs and other medical products. The Harvard Pilgrim Health Care Institute (HPHCI) has led the Sentinel System since the inception of … real-world evidence. TriNetX combines real time access to longitudinal clinical data with state-of-the-art analytics to answer complex research questions at the speed of thought. The TriNetX platform is HIPAA and GDPR …

Kaiser Permanente develops machine learning tool to predict HIV risk | FierceHealthcare | 7/8/2019

… about HIV risk, Volk said. Kaiser Permanente Northern California has a comprehensive electronic health record that tracks many demographic and clinical data points for its members. “Development of the tool required a setting like KP … of Research. Marcus is now at Harvard Medical School and Harvard Pilgrim Health Care Institute. The project was supported by the Kaiser Permanente Northern California Community Benefit Research Program, the National Institute of Allergy and …

Inland Empire Health Plan

Digital health records are bringing better care and less cost to California consumers | The Business Journals | 9/11/2019

… Academic studies show that the data networks are contributing to significant improvements in patient care through giving providers access to clinical data critical for treating patients in the hospital, an emergency room, in an ambulatory … provider groups and health plans including Blue Shield of California, Inland Empire Health Plan and Anthem. Most recently, Stanford Health Care, San Diego-based Scripps Health, Southern California hospital network AHMC Healthcare, Northridge-based Heritage …

Manifest MedEx | 6/21/2019

Anthem Blue Cross of California Inland Empire Health Plan Manifest MedEx is helping healthcare providers care for patients across the State of California every day. Together, their goal is to transform the healthcare landscape across … undertaken. Adding to the complexity and challenge of this project, clinical data migrations were added to the mix. According to J2’s Principal Consultant Jim Powers, “We wanted to provide a seamless experience for providers …

Kaplan Meier

A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network | 12/4/2019

… of 14 Gene Expression Omnibus (GEO) datasets regarding NSCLC were collected, including GSE19188, GSE30219, GSE10072, GSE7670, GSE2514, GSE32863, GSE21933, GSE40275, GSE12472, GSE80796, GSE8500, GSE85841, GSE19027, and GSE11969. The TCGA-LUAD RNAseq data and clinical data (level 3) of the NSCLC and ANT (adjacent normal tissue) samples were downloaded from the TCGA data portal (up to June 29, 2018) (Table 1 ) [ 13 – 15 ]. These datasets were processed and analyzed by following …

SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways | 12/3/2019

… human cancers. Herein, we investigated the precise role of SKA1 in the progression and malignant phenotype of human glioma. Methods Bioinformatic analysis was carried out based on the RNA-seq data and corresponding clinical data from GEO, TCGA and CGGA databases. Western blot was performed to analyze the expression of SKA1 in clinical samples and signaling pathway proteins in glioma cells, respectively. CCK8 assay, colony forming assay and EdU assay …

Kenji Yasukawa

Biotechs Move Forward Developing Latest Targeted Therapies for Acute Myeloid Leukemia | PR Newswire | 12/4/2019

… the potential to deliver unprecedented and sustained value to patients, and even to curing diseases with a single intervention,” said Kenji Yasukawa , President and CEO, Astellas. “Audentes has developed a robust pipeline of promising product … with the FDA so that we can continue to build clinical data for additional retinal indications beyond wet AMD for ONS-5010,” said Lawrence A. Kenyon , President, Chief Executive Officer and Chief Financial Officer. “Anti …

Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics | Business Wire | 12/3/2019

… Therapeutics 4 hrs ago TOKYO & SAN FRANCISCO–(BUSINESS WIRE)–Dec 2, 2019– Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “ Astellas ”) and Audentes Therapeutics, Inc. (NASDAQ: BOLD, Chairman and CEO: Matthew R … Audentes’ product candidates, the timing of Audentes’ presentation of non-clinical data and the timing and nature of Audentes’ preclinical studies, clinical trials and manufacturing activities. In some cases, forward-looking statements may be identified …

Michael J. Fox

Researchers Leverage CBD’s Medical Properties to Fight a Plethora of Ailments | Benzinga | 12/4/2019

… on marijuana and cannabinoids has given promising but conflicting signals,” said Rachel Dolhun , MD, Vice President, Medical Communications at The Michael J. Fox Foundation for Parkinson’s Research. “This therapy may represent a future treatment option … months from jurisdictions around the world, including the United States .” Clinical data for Eltoprazine in PD-LID The Eltoprazine study in 22 subjects with long standing PD-LID was a randomized, four-way crossover design …

Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer’s Disease (CTAD) 2019 Conference Nasdaq:AVXL | Globe Newswire | 12/4/2019

… 104-Week) Timepoint Abundance of Lachnospiraceae and Enterobacteriaceae Families as Potential Biomarker of Response from a 2-Year Study Interim Clinical Data Analysis of ANAVEX ® 2-73 ( blarcamesine ) NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) – Anavex … its potential to treat additional CNS disorders, including epilepsy. The Michael J. Fox Foundation for Parkinson’s Research previously awarded Anavex a research grant, which fully funded a preclinical study to develop ANAVEX®2-73 ( blarcamesine ) for …

Michael Klein

iCAD’s ProFound AI Joins Nuance AI Marketplace for Diagnostic Imaging | Globe Newswire | 12/4/2019

… of radiology as technology continues to evolve and health care professionals now have access to more data than ever,” said Michael Klein, Chairman and CEO of iCAD. “ProFound AI is a powerful tool and the … the algorithm allows for continuously improved performance via ongoing updates. Clinical data from a large reader study involving ProFound AI for DBT were recently published in Radiology: Artificial Intelligence. According to study findings, ProFound AI …

iCADs ProFound AI Joins Nuance AI Marketplace for Diagnostic Imaging | Financial Buzz | 12/4/2019

… of radiology as technology continues to evolve and health care professionals now have access to more data than ever,” said Michael Klein, Chairman and CEO of iCAD. “ProFound AI is a powerful tool and the … the algorithm allows for continuously improved performance via ongoing updates. Clinical data from a large reader study involving ProFound AI for DBT were recently published in Radiology: Artificial Intelligence. According to study findings, ProFound AI …

Fred Hutchinson

Keto, Fat and Cancer: It’s Complicated | 12/3/2019

… heart disease, diabetes, cancer and all the rest, trying to identify that nutritional silver bullet. Disease detectives (aka epidemiologists) at Fred Hutchinson Cancer Research Center have been studying dietary fat and health for more than … of cancer keto resources online. What there isn’t , is much clinical data. There are many keto diet cancer trials in the works , in research centers from Florida to Frankfurt. But some are still recruiting, others …

Immunomic Therapeutics’ Collaborator, University of Florida Presents New Clinical Data from ATTAC-II Study in GBM at the 2019 Society for Neurology (SNO) Annual Meeting | Business Wire | 11/21/2019

… and co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy, and his team will present new clinical data at the 2019 Society for Neurology (SNO) Annual Meeting being held in Phoenix … formed several academic collaborations with leading Immuno-oncology researchers at Fred Hutchinson Cancer Research Institute, Johns Hopkins University of Medicine, and Duke University. ITI maintains its headquarters in Rockville, Maryland. For more information, please visit …

David M. Reese

Amgen Announces Data Being Presented At ASH 2019 | BioSpace | 12/3/2019

THOUSAND OAKS, Calif. , Dec. 2, 2019 /PRNewswire/ – Amgen (NASDAQ:AMGN) today announced new clinical data from its oncology in-line products and pipeline that will be presented at the 61 st American Society of Hematology … treatment of patients with relapsed or refractory multiple myeloma,” said David M. Reese , M.D., executive vice president of Research and Development at Amgen. Additionally, data from study AALL1331 conducted by the Children’s Oncology Group (COG …

Henry B. Gonzalez

Oncternal Therapeutics to Present Cirmtuzumab Clinical Data Updates at 2019 ASH Annual Meeting and San Antonio Breast Cancer Symposium | Malvern Daily Record | 12/3/2019

… Therapeutics, Inc. ( Nasdaq: ONCT ), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that clinical data updates for cirmtuzumab, its investigational anti-ROR1 monoclonal antibody, will be presented at … 2019 Session Time: 5:00 PM - 7:00 PM Location: Hall 1 (Henry B. Gonzalez Convention Center) About Cirmtuzumab Cirmtuzumab is an investigational, potentially first-in-class monoclonal antibody targeting ROR1, or Receptor tyrosine kinase-like Orphan …

Biocept’s Liquid Biopsy CTC Testing for Breast Cancer to Be Featured in Poster Presentation at the 2019 San Antonio Breast Cancer Symposium® | PR Newswire | 12/3/2019

clinical data supporting the use of its Target Selector™ CTC platform as an aid in the monitoring and treatment of breast cancer will be presented in a poster session at the 2019 San Antonio Breast Cancer Symposium® (SABCS). The Symposium is being held December 10-14 , at the Henry B. Gonzalez Convention Center in Austin, Texas . Information about the SABCS can be found at www.sabcs.org/2019-SABCS . Poster and session details …

Matthew R. Patterson

Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics | Business Wire | 12/3/2019

… Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “ Astellas ”) and Audentes Therapeutics, Inc. (NASDAQ: BOLD, Chairman and CEO: Matthew R. Patterson, “ Audentes ”), today announced that they have entered into a definitive agreement for … Audentes’ product candidates, the timing of Audentes’ presentation of non-clinical data and the timing and nature of Audentes’ preclinical studies, clinical trials and manufacturing activities. In some cases, forward-looking statements may be identified …

Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics – Company Announcement - FT.com | Financial Times | 12/3/2019

… Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa , Ph.D., “ Astellas ”) and Audentes Therapeutics , Inc. (NASDAQ: BOLD, Chairman and CEO: Matthew R. Patterson , “ Audentes ”), today announced that they have entered into a definitive agreement for … Audentes’ product candidates, the timing of Audentes’ presentation of non-clinical data and the timing and nature of Audentes’ preclinical studies, clinical trials and manufacturing activities. In some cases, forward-looking statements may be identified …

Michael Nall

Biocept’s Liquid Biopsy CTC Testing for Breast Cancer to Be Featured in Poster Presentation at the 2019 San Antonio Breast Cancer Symposium® | PR Newswire | 12/3/2019

… offerings designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that clinical data supporting the use of its Target Selector™ CTC platform as an aid in … their patients with breast cancer,” said Biocept’s President and CEO Michael Nall . “Our liquid biopsy platform provides the unique ability to utilize our proprietary CTC testing to capture and count cancer cells as well as …

Phil Rowlands

Takeda Presents Long-Term Data in ALK+ NSCLC Showing ALUNBRIG® (brigatinib) Continues to Demonstrate Superiority in the First-Line After Two Years of Follow-Up | 12/3/2019

… to developing products that seek to advance the lung cancer treatment landscape and address the unmet needs of patients,” said Phil Rowlands, Head, Oncology Therapeutic Area Unit. “We are proud of the progress made thus … fetal harm when administered to pregnant women. There are no clinical data on the use of ALUNBRIG in pregnant women. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential …